F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 44 filers reported holding F-STAR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $858,888 | +146.8% | 135,900 | +100.0% | 0.00% | – |
| Q3 2022 | $348,000 | +4.5% | 67,950 | +27.8% | 0.00% | – |
| Q2 2022 | $333,000 | +76.2% | 53,150 | 0.0% | 0.00% | – |
| Q1 2022 | $189,000 | -18.2% | 53,150 | +15.6% | 0.00% | – |
| Q4 2021 | $231,000 | -31.5% | 45,970 | 0.0% | 0.00% | – |
| Q3 2021 | $337,000 | +56.7% | 45,970 | +83.4% | 0.00% | – |
| Q2 2021 | $215,000 | – | 25,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |